Allex
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Category
- Health Care Supplement
ViroMed
- Verified Certificate
-
10
Product name | Allex | Certification | - |
---|---|---|---|
Category | Health Care Supplement | Ingredients | - |
Keyword | immunity , hardy kiwi extract , immune hypersensitivity | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | South Korea | Stock | - |
Supply type | - | HS code | - |
Product Information
Allex
Nutraceutical for Allergies and Allergic Disease
│ DESCRIPTION │
Allex is a functional food product made with hardy kiwi extract as the main ingredient. Allex was developed to help those suffering from immune hypersensitivity and is successfully marketed in Korea.
Allex is the first product to receive approval for ‘help improve immune hypersensitivity’ functional claim from the KFDA. Results from human trial have already been published in an international scientific journal and patents have been issued from 14 different countries.
The human trial for hardy kiwi extract, conducted at Seoul National University Hospital, showed improvements in various immune hypersensitivity related markers (IgE, ECP, eotaxin, etc.) and was able to complete KFDA’s functionality evaluation with it.
│ CLINICAL TRIAL │
The ability of hardy kiwi extract (PG102) to improve hyper-immune reactions was verified through clinical trials run by Korea’s leading researchers at Seoul National University Hospital’s Division of Allergy and Clinical Immunology.
Name of trial: Effect of Edible Actinidia arguta Extract (PG102) on Allergy-Related Primary Risk Factors.(randomized, double-blind, placebo comparison)
Locations of trial: Division of Allergy and Clinical Immunology at Seoul National University Hospital and Bundang Hospital.
Results of trial: PG102 had no observed side effects while safely improving allergy reaction levels. It was judged to have superior properties as a nutraceutical in controlling inflammation and fluids and inhibiting the advancement of immune reactions.
│ FEATURES │
Product made with natural substance.
Introduced as a new alternative for immune hypersensitivity.
Selected as one of five functional food products good for immunity by KHSA.
(Korea Health Supplements Association).
│ HEALTH INFORMATION │
Immune hypersensitivity refers to body’s overreaction to substances such as pollen, yellow dust, cold wind, dust mite, smog, specific food, etc.
Immune hypersensitivity can occur due to genetics or when exposed to causative substances while the immune system is overly sensitive due to environmental pollution.
Ex)Skin: Itchness/redness/hives, Respiratory: Dry cough/difficulty breathing, Nose: Runny nose/itchy nose/stuffy nose.
26.8 % (2011) of Korean population are known to suffer from immune hypersensitivity. We have already been receiving inquiries regarding raw material/product from Thailand.
Allex does not contain any artificial coloring or flavoring and does not have any known side effects, which makes it suitable for those wanting to improve immune hypersensitivity safely.
Usage: 2 capsules, 2 times daily, with water
Specification: 120 caps/bottle.
Shelf Life: Two years
Storage: Keep in a dry and cool place.
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Yongsoo Kim
- Address
- #5, Bldg, 203, Seoul National University, 1, Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea
- Product Category
- Health Care Supplement,Skin Care Set
- Year Established
- 1996
- No. of Total Employees
- 51-100
- Company introduction
-
ViroMed Co., Ltd. (ViroMed), a leading biopharmaceutical company focusing on the development of innovative medicine, was established in 1996 and is headquartered in Seoul, Korea with a US presence in Atlanta Area. ViroMed has been listed on the KOSDAQ stock exchange (084990) since 2005.
ViroMed has assembled a diverse pipeline of novel biologics and Botanical therapeutics in the areas of cardiovascular disease, cancer and immune disorder, with eight projects in clinical stages in the US, Korea, and China. The company has established several key partnerships with Reyon Pharm. (Korea), PMG Pharm. (Korea) and Beijing Northland Biotech (China).
The founder of ViroMed is Professor Sunyoung Kim of Seoul National University (SNU), who holds academic degrees from SNU, MIT, Harvard and Oxford, and also served as an assistant professor at Harvard Medical School and a postdoctoral fellow at MIT. Rallied under the leadership of Prof. Kim, experts from various fields have been united to achieve one goal – to cure the incurables
- Main Product